Physician profile
Sean Patrick Goolsby
NPI 1558654012
$1,494.02
in general payments reported to CMS, 2019-2025
11 companies · $62.26 in 2025
The $62.26 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $133 · 2021: $231 · 2022: $61.56 · 2023: $51.80 · 2024: $954 · 2025: $62.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $764 · Honoraria: $185 · Food and Beverage: $72.15 · Consulting Fee: $25.00 · Entertainment: $21.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $764.00 |
| Honoraria | $185.22 |
| Food and Beverage | $72.15 |
| Consulting Fee | $25.00 |
| Entertainment | $21.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Benco Dental Supply Co. | $949.22 | 2023-2024 | |
| Align Technology, INC. | $210.20 | 2020-2023 | Invisalign, Itero |
| Dental Health Products, INC. | $100.71 | 2021 | |
| Coltene Whaledent INC. | $60.30 | 2020-2024 | |
| Dentsply Sirona INC | $46.98 | 2021-2025 | Atlantis |
| Nobel Biocare USA | $35.15 | 2020 | |
| Biolase, INC. | $32.93 | 2022 | |
| Kerr Corporation | $19.38 | 2022 | |
| Gc America INC. | $15.32 | 2025 | Equia, G-Aenial, Everstick |
| Solventum Corporation | $13.94 | 2025 | 3m Filtek, 3m Clinpro, 3m Scotchbond |
| Voco America INC. | $9.89 | 2023 | Admira Fusion, Voco Profluorid Varnish, Futurabond U |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Goolsby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.